Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
ADPT Transcript
Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call Transcript
Positive5-5
The earnings call reflects strong revenue growth driven by MRD, improved EBITDA in the MRD segment, and optimistic guidance with margin expansion and increased pharma partnerships. Despite some concerns about expenses and ongoing investments, the market strategy and business updates are robust. The Q&A highlights progress in community account engagement, reimbursement profiles, and EHR integration, with positive analyst sentiment. While some uncertainties remain, particularly around Medicare bundle increases and contract transitions, the overall sentiment is positive, anticipating a 2-8% stock price increase.
Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call Transcript
Positive2-6
The company reported strong financial performance with significant revenue growth, improved margins, and a substantial reduction in cash burn. Raised revenue guidance and a positive EBITDA outlook further bolster confidence. Despite some conservative growth assumptions and lack of specific contract details, the overall sentiment is positive, supported by strong MRD performance and strategic partnerships like Pfizer.
Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-12
Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call summary and Q&A section reveal several positive aspects: raised revenue guidance, improved margins, and strong growth in MRD volumes. The company's strategic partnerships and regulatory advancements, along with a clear path to profitability, are positive indicators. Despite some vague management responses, the overall sentiment is optimistic. The stock is likely to see a positive movement, with increased MRD revenue and improved cash burn guidance contributing to investor confidence.
ADPT Slides
ADPT Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
